References
- Costa E, Silva JA. Nations for mental health: an action programme on mental health for underserved populations; 1998.
- Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J. 2005;150(6):1115–1121. doi:10.1016/j.ahj.2005.02.007
- Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425–448. doi:10.1146/annurev-clinpsy-032813-153657
- Solmi M, Seitidis G, Mavridis D, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019. Mol Psychiatry. 2023. doi:10.1038/s41380-023-02138-4
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Publishing; 2013.
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators G 2017 D and II and P. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
- Chan MK, Gottschalk MG, Haenisch F, et al. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Prog Neurobiol. 2014;122:45–72. doi:10.1016/j.pneurobio.2014.08.002
- Wagh VV, Vyas P, Agrawal S, Pachpor TA, Paralikar V, Khare SP. Peripheral blood-based gene expression studies in schizophrenia: a systematic review. Front Genet. 2021;12. doi:10.3389/fgene.2021.736483
- Hess JL, Tylee DS, Barve R, et al. Transcriptomic abnormalities in peripheral blood in bipolar disorder, and discrimination of the major psychoses. Schizophr Res. 2020;217:124–135. doi:10.1016/j.schres.2019.07.036
- Zhu L, Wu X, Xu B, et al. The machine learning algorithm for the diagnosis of schizophrenia on the basis of gene expression in peripheral blood. Neurosci Lett. 2021:745. doi:10.1016/j.neulet.2020.135596
- Ke P-F, Xiong D-S, Li J-H, et al. An integrated machine learning framework for a discriminative analysis of schizophrenia using multi-biological data. Sci Rep. 2021;11(1):14636. doi:10.1038/s41598-021-94007-9
- Bhandari N, Walambe R, Kotecha K, Khare SP. A comprehensive survey on computational learning methods for analysis of gene expression data. Front Mol Biosci. 2022;9:907150. doi:10.3389/fmolb.2022.907150
- Liu S, Lu T, Zhao Q, et al. A machine learning model for predicting patients with major depressive disorder: a study based on transcriptomic data. Front Neurosci. 2022;16. doi:10.3389/fnins.2022.949609
- Yu JS, Xue AY, Redei EE, Bagheri N. A support vector machine model provides an accurate transcript-level-based diagnostic for major depressive disorder. Transl Psychiatry. 2016;6(10):e931. doi:10.1038/tp.2016.198
- Wu X, Zhu L, Zhao Z, et al. Application of machine learning in diagnostic value of mRNAs for bipolar disorder. Nord J Psychiatry. 2022;76(2):81–88. doi:10.1080/08039488.2021.1937311
- Hess JL, Tylee DS, Barve R, et al. Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia. Schizophr Res. 2016;176(2–3):114–124. doi:10.1016/j.schres.2016.07.006
- Van Zelst C. Stigmatization as an environmental risk in schizophrenia: a user perspective. Schizophr Bull. 2009;35(2):293. doi:10.1093/SCHBUL/SBN184
- Adil M, Atiq I, Ellahi A. Stigmatization of schizophrenic individuals and its correlation to the fear of violent offence. Should we be concerned? Ann Med Surg. 2022;82:104666. doi:10.1016/J.AMSU.2022.104666
- Lauber C, Rössler W. Stigma towards people with mental illness in developing countries in Asia. Int Rev Psychiatry. 2007;19(2):157–178. doi:10.1080/09540260701278903
- Thirthalli J, Kumar CN. Stigma and disability in schizophrenia: developing countries’ perspective. Int Rev Psychiatry. 2012;24(5):423–440. doi:10.3109/09540261.2012.703644
- Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;20(3):273–297. doi:10.1007/BF00994018
- Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A. 2002;99(10):6567. doi:10.1073/PNAS.082099299
- Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–210. doi:10.1093/nar/30.1.207
- Parkinson H, Kapushesky M, Shojatalab M, et al. ArrayExpress - A public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 2007;35(Suppl 1):747–750. doi:10.1093/nar/gkl995
- R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
- Braschi B, Denny P, Gray K, et al. Genenames.org: the HGNC and VGNC resources in 2019. Nucleic Acids Res. 2019;47(D1):D786–D792. doi:10.1093/nar/gky930
- Bolstad B preprocessCore: a collection of preprocessing functions; 2020. Available from: https://github.com/bmbolstad/preprocessCore. Accessed April 29, 2024.
- Leek JT, Johnson WE, Parker HS, et al. Package ”sva” Title Surrogate Variable Analysis; 2020. Available from: https://bioconductor.org/packages/sva/. Accessed April 29, 2024.
- Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47–e47. doi:10.1093/NAR/GKV007
- Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F e1071: misc Functions of the Department of Statistics, Probability Theory Group (Formerly: E1071), TU Wien. R. 2021. Available from: https://CRAN.R-project.org/package=e1071. Accessed April 29, 2024.
- Hastie T, Tibshirani R, Narasimhan B, Chu G pamr: pam: prediction analysis for microarrays. R package; 2019. Available from: https://cran.r-project.org/package=pamr. Accessed April 29, 2024.
- Raudvere U, Kolberg L, Kuzmin I, et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191–W198. doi:10.1093/nar/gkz369
- Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/NAR/GKY1131
- Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
- Chin C-H, Chen S-H, H-H W, C-W H, M-T K, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
- First MB, Williams JB. Structured clinical interview for DSM-5-Research version. Am Psychiatry Assoc. 2015;5:1–94.
- Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi:10.1093/schbul/13.2.261
- Andrews S FastQC: a quality control tool for high throughput sequence data; 2010. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/. Accessed April 29, 2024.
- Frankish A, Diekhans M, Ferreira AM, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019;47(D1):D766–D773. doi:10.1093/nar/gky955
- Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37(8):907–915. doi:10.1038/s41587-019-0201-4
- Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923–930. doi:10.1093/bioinformatics/btt656
- Zaiontz C Real Statistics Using Excel; 2020. Available from: www.real-statistics.com. Accessed April 29, 2024.
- Hammer Ø, Harper DAT, Ryan PD Past: paleontological statistics software package for education and data analysis; 2001.
- Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics. 2005;21(20):3940–3941. doi:10.1093/BIOINFORMATICS/BTI623
- Bousman CA, Chana G, Glatt SJ, et al. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):494–502. doi:10.1002/ajmg.b.31006
- van Beveren NJM, Buitendijk GHS, Swagemakers S, et al. Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients. PLoS One. 2012;7(2). doi:10.1371/journal.pone.0032618
- de Jong S, Boks MPM, Fuller TF, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One. 2012;7(6):e39498. doi:10.1371/journal.pone.0039498
- Stoll G, Pietiläinen OPH, Linder B, et al. Deletion of TOP3β, a component of FMRP-containing mRNPs, contributes to neurodevelopmental disorders. Nat Neurosci. 2013;16(9):1228–1237. doi:10.1038/nn.3484
- Xu Y, Yao Shugart Y, Wang G, et al. Altered expression of mRNA profiles in blood of early-onset schizophrenia. Sci Rep. 2016;6(1):16767. doi:10.1038/srep16767
- Kumarasinghe N, Beveridge NJ, Gardiner E, et al. Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication. Int J Neuropsychopharmacol. 2013;16(07):1483–1503. doi:10.1017/S1461145713000035
- Vachev TI, Stoyanova VK, Ivanov HY, Minkov IN, Popov NT. Investigation of Fasciculation and Elongation Protein ζ-1 (FEZ1) in peripheral blood reveals differences in gene expression in patients with schizophrenia. Balk J Med Genet. 2015;18(1):31–38. doi:10.1515/bjmg-2015-0003
- V. TS, Hecher L, Schafflick D, et al. Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia. Transl Psychiatry. 2019;9(1). doi:10.1038/S41398-019-0486-6
- Okazaki S, Boku S, Otsuka I, et al. The cell cycle-related genes as biomarkers for schizophrenia. Prog Neuro Psychopharmacol Biol Psychiatr. 2016;70:85–91. doi:10.1016/j.pnpbp.2016.05.005
- Tsuang MT, Nossova N, Yager T, et al. Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am J Med Genet. 2005;133(1):1–5. doi:10.1002/ajmg.b.30161
- Middleton FA, Pato CN, Gentile KL, et al. Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approaches. Am J Med Genet Part B Neuropsychiatr Genet. 2005;136B(1):12–25. doi:10.1002/ajmg.b.30171
- Zhang H, Xie Z, Yang Y, Zhao Y, Zhang B, Fang J. The correlation-base-selection algorithm for diagnostic schizophrenia based on blood-based gene expression signatures. Biomed Res Int. 2017;2017. doi:10.1155/2017/7860506
- Dmitrieva E, Smirnova L, Seregin A, Zgoda V, Semke A, Ivanova S. Proteomic profile of serum from patients with schizophrenia spectrum disorders. PeerJ. 2022;10:e13907. doi:10.7717/peerj.13907
- Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851–876. doi:10.1017/S1461145707008401
- Gonzalez-liencres C, Tas C, Brown EC, et al. Oxidative stress in schizophrenia: a case – control study on the effects on social cognition and neurocognition. BMC Psychiatry. 2014:1–9. doi:10.1186/s12888-014-0268-x
- Yovel G, Sirota P, Mazeh D, Shakhar G, Rosenne E, Ben-Eliyahu S. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun. 2000;14(3):153–169. doi:10.1006/brbi.1999.0574
- Van Kesteren CFMG, Gremmels H, De Witte LD, et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. 2017;7(3). doi:10.1038/tp.2017.4
- Parellada E, Gassó P. Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia. Transl Psychiatry. 2021;11(1):271. doi:10.1038/s41398-021-01385-9
- Ripke S, Neale BM, Corvin A, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427. doi:10.1038/nature13595
- Pardiñas AF, Holmans P, Pocklington AJ, et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat Genet. 2018;50(3):381–389. doi:10.1038/s41588-018-0059-2
- Fromer M, Roussos P, Sieberts SK, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19(11):1442–1453. doi:10.1038/NN.4399
- Gardiner EJ, Cairns MJ, Liu B, et al. Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells. J Psychiatr Res. 2013;47(4):425–437. doi:10.1016/j.jpsychires.2012.11.007
- Sun L, Cheng Z, Zhang F, Xu Y. Gene expression profiling in peripheral blood mononuclear cells of early-onset schizophrenia. Genomics Data. 2015;5:169–170. doi:10.1016/j.gdata.2015.04.022
- Yang Q, Li Y, Li B, Gong Y. A novel multi-class classification model for schizophrenia, bipolar disorder and healthy controls using comprehensive transcriptomic data. Comput Biol Med. 2022;148. doi:10.1016/J.COMPBIOMED.2022.105956